{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:37:18Z","timestamp":1772087838766,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Thymic epithelial tumors are rare cancers of the anterior mediastinum with heterogeneous clinical behaviors. Despite numerous attempts to characterize their mutational landscape, a comprehensive understanding of their genetic alterations remains limited due to small sample sizes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To address this gap, we conducted a systematic meta-analysis of somatic mutations reported in 729 patients across twenty studies, integrating single-variant data into a unified dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This approach identified three molecular subgroups with distinct biological and clinical features. Tumors harboring GTF2I mutations were typically indolent, exhibited low mutational burden, and showed enrichment in pathways related to cell adhesion. Tumors with TP53 mutations displayed high mutational load, activation of receptor tyrosine kinase and mitogenic signaling, and corresponded to aggressive clinical behavior. Tumors lacking both GTF2I and TP53 mutations revealed intermediate pro les, characterized by alterations in epigenetic regulation and extracellular matrix organization. Mutational signature analysis indicated that age-related processes predominate in less aggressive tumors, while DNA repair de ciency characterizes those with TP53 mutations. Network and pathway analyses revealed convergent oncogenic hubs and distinct signaling dependencies across subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This large-scale integrative study provides a re ned map of the genetic landscape of thymic epithelial tumors, highlights biologically meaningful heterogeneity, and establishes a framework to guide future research and the development of targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1781510","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:28:33Z","timestamp":1772083713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic landscape and subgroup stratification of thymic epithelial tumors: a systematic meta-analysis of next-generation sequencing data"],"prefix":"10.3389","volume":"16","author":[{"given":"Eleonora","family":"Pardini","sequence":"first","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Barachini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Montali","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Sofia","family":"Burzi","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisella","family":"Sardo Infirri","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Tagliafierro","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Petrini","sequence":"additional","affiliation":[{"name":"Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa","place":["Pisa, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.esmoop.2023.101627","article-title":"Genomic characterization of thymic epithelial tumors in a real-world dataset","volume":"8","author":"Kurokawa","year":"2023","journal-title":"ESMO Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010166","article-title":"Molecular and functional key features and oncogenic drivers in thymic carcinomas","volume":"16","author":"Barachini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.esmoop.2021.100188","article-title":"Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM)","volume":"6","author":"Conforti","year":"2021","journal-title":"ESMO Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71\"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx094","article-title":"The genomic and epigenomic landscape in thymic carcinoma","volume":"38","author":"Saito","year":"2017","journal-title":"Carcinogenesis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12885-017-3282-9","article-title":"Characterization of genetic aberrations in a single case of metastatic thymic adenocarcinoma","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0546","article-title":"Whole exome sequencing of thymic neuroendocrine tumor with ectopic ACTH syndrome","volume":"176","author":"Li","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.11.08","article-title":"A mutational profile in multiple thymic squamous cell carcinoma","volume":"8","author":"Jin","year":"2019","journal-title":"Gland Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164018","article-title":"Whole exome sequencing of thymoma patients exhibiting exceptional responses to pemetrexed monotherapy","volume":"15","author":"Tanaka","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060572","article-title":"Whole genome and transcriptome sequencing of a B3 thymoma","volume":"8","author":"Petrini","year":"2013","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1038\/oncsis.2014.25","article-title":"ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma","volume":"3","author":"Belani","year":"2014","journal-title":"Oncogenesis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1224491","article-title":"Somatic mutations of thymic epithelial tumors with myasthenia gravis","volume":"13","author":"Pardini","year":"2023","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.70205","article-title":"Somatic mutations of thymic epithelial tumors identified in the prospective THYMOGENE trial","volume":"16","author":"Pardini","year":"2025","journal-title":"Thorac Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1015","article-title":"Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses","volume":"4","author":"Wheler","year":"2013","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2014.08.020","article-title":"Genetic profiling of thymic carcinoma using targeted next-generation sequencing","volume":"86","author":"Shitara","year":"2014","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of epigenetic regulatory genes are common in thymic carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000397","article-title":"Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis","volume":"10","author":"Moreira","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lungcan.2016.01.004","article-title":"Medical treatment involving investigational drugs and genetic profile of thymic carcinoma","volume":"93","author":"Asao","year":"2016","journal-title":"Lung Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-016-0144-8","article-title":"Molecular profiling of thymoma and thymic carcinoma: genetic differences and potential novel therapeutic targets","volume":"23","author":"Enkner","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2020.96537","article-title":"Genomic profiling of thymoma using a targeted high-throughput approach","volume":"20","author":"Peric","year":"2024","journal-title":"Arch Med Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143388","article-title":"Targeted next-generation sequencing of thymic epithelial tumours revealed pathogenic variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas","volume":"14","author":"Szpechcinski","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.modpat.2022.100008","article-title":"Constant p.L424H mutation in GTF2I in micronodular thymomas with lymphoid stroma: evidence supporting close relationship with type A and AB thymomas","volume":"36","author":"Hsieh","year":"2023","journal-title":"Mod Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s42003-022-04002-7","article-title":"Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice","volume":"5","author":"Giorgetti","year":"2022","journal-title":"Commun Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.08.008","article-title":"A knock-in mouse model of thymoma with the GTF2I L424H mutation","volume":"17","author":"He","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.06.002","article-title":"Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)","volume":"35","author":"Proto","year":"2024","journal-title":"Ann Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.04.009","article-title":"STYLE (NCT03449173): A phase 2 trial of sunitinib in patients with type B3 thymoma or thymic carcinoma in second and further lines","volume":"18","author":"Proto","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac115","article-title":"Comprehensive genomic profiling of 274 thymic epithelial tumors unveils oncogenic pathways and predictive biomarkers","volume":"27","author":"Girard","year":"2022","journal-title":"Oncologist"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1781510\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:28:34Z","timestamp":1772083714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1781510\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":38,"alternative-id":["10.3389\/fonc.2026.1781510"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1781510","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1781510"}}